Rheumatic Myocarditis: A Poorly Recognized Etiology of Left Ventricular Dysfunction in Valvular Heart Disease Patients

被引:1
|
作者
Rosa, Vitor Emer Egypto [1 ]
Lopes, Mariana Pezzute [1 ]
Spina, Guilherme Sobreira [1 ]
Soares Junior, Jose [1 ]
Salazar, David [1 ]
Romero, Cristhian Espinoza [1 ]
Lottenberg, Marcos Pita [1 ]
de Santis, Antonio [1 ]
Pires, Lucas Jose Neves Tachotti [1 ]
Goncalves, Luis Fernando Tonello [1 ]
Fernandes, Joao Ricardo Cordeiro [1 ]
Sampaio, Roney Orismar [1 ]
Tarasoutchi, Flavio [1 ]
机构
[1] Univ Sao Paulo, Clin Hosp, Heart Inst InCor, Sao Paulo, Brazil
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2021年 / 8卷
关键词
myocarditis; rheumatic fever; rheumatic heart disease; valvular heart disease; heart failure; FEVER; ECHOCARDIOGRAPHY; DIAGNOSIS; CHILDREN; PREVALENCE;
D O I
10.3389/fcvm.2021.676694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Heart failure occurs in similar to 10% of patients with acute rheumatic fever (RF), and several studies have shown that cardiac decompensation in RF results primarily from valvular disease and is not due to primary myocarditis. However, the literature on this topic is scarce, and a recent case series has shown that recurrent RF can cause ventricular dysfunction even in the absence of valvular heart disease. Methods: The present study evaluated the clinical, laboratory and imaging characteristics of 25 consecutive patients with a clinical diagnosis of myocarditis confirmed by 18F-FDG PET/CT or gallium-67 cardiac scintigraphy and RF reactivation according to the revised Jones Criteria. Patients underwent three sequential echocardiograms at (1) baseline, (2) during myocarditis and (3) post corticosteroid treatment. Patients were divided according to the presence (Group 1) or absence (Group 2) of reduced left ventricular ejection fraction (LVEF) during myocarditis episodes. Results: The median age was 42 (17-51) years, 64% of patients were older than 40 years, and 64% were women. Between Group 1 (n = 16) and in Group 2 (n = 9), there were no demographic, echocardiographic or laboratory differences except for NYHA III/IV heart failure (Group 1: 100.0% vs. Group 2: 50.0%; p = 0.012) and LVEF (30 [25-37] vs. 56 [49-62]%, respectively; p < 0.001), as expected. Group 1 patients showed a significant reduction in LVEF during carditis with further improvement after treatment. There was no correlation between LVEF and valvular dysfunction during myocarditis. Among all patients, 19 (76%) underwent 18F-FDG PET/CT, with a positive scan in 68.4%, and 21 (84%) underwent gallium-67 cardiac scintigraphy, with positive uptake in 95.2%, there was no difference between these groups. Conclusion: Myocarditis due to rheumatic fever reactivation can cause left ventricular dysfunction despite valvular disease, and it is reversible after corticosteroid treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Etiology of Valvular Heart Disease in the 21st Century
    Boudoulas, Konstantinos Dean
    Borer, Jeffrey S.
    Boudoulas, Harisios
    CARDIOLOGY, 2013, 126 (03) : 139 - 152
  • [32] Heart failure and left ventricular dysfunction in older patients with chronic kidney disease: the China Hypertension Survey (2012-2015)
    Wang, Xin
    Hao, Guang
    Chen, Lu
    Zhang, Lin-Feng
    Chen, Zuo
    Kang, Yu-Ting
    Yang, Ying
    Zheng, Cong-Yi
    Zhou, Hao-Qi
    Wang, Zeng-Wu
    Gao, Run-Lin
    JOURNAL OF GERIATRIC CARDIOLOGY, 2020, 17 (10) : 597 - 603
  • [33] Double whammy: Rheumatic heart disease associated with left ventricular noncompaction
    Banerji, Antara
    Tiwari, Pradyot
    JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2021, 7 (01) : 83 - 84
  • [34] Valvular Heart Disease in a Young Israeli Ethiopian Immigrant Population From the Gondar Region With Implications for Rheumatic Heart Disease
    Fink, Daniel Lyon
    Chaiter, Yoram
    Menahem, Samuel
    Farkash, Rivka
    Machluf, Yossy
    FRONTIERS IN PUBLIC HEALTH, 2018, 6
  • [35] Predictors of Chronic Valvular Disease in Patients With Rheumatic Carditis
    Yilmazer, Murat Muhtar
    Oner, Taliha
    Tavli, Vedide
    Cilengiroglu, Ozgul Vupa
    Guven, Baris
    Mese, Timur
    Vitrinel, Ayca
    Devrim, Ilker
    PEDIATRIC CARDIOLOGY, 2012, 33 (02) : 239 - 244
  • [36] Poorly suited heart valve prostheses heighten the plight of patients with rheumatic heart disease
    Scherman, Jacques
    Zilla, Peter
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 318 : 104 - 114
  • [37] Pattern of Valvular Involvement in Rheumatic Heart Disease Patients in a Tertiary Care Hospital of Western Nepal
    Kafle, Ram Chandra
    Alurkar, Vijay Madhab
    Paudel, Navaraj
    Jha, Girija Shankar
    NEPALESE HEART JOURNAL, 2016, 13 (02) : 29 - 31
  • [38] Autoimmune myocarditis is not associated with left ventricular systolic dysfunction
    Mirna, Moritz
    Paar, Vera
    Kraus, Theo
    Sotlar, Karl
    Wernly, Bernhard
    Pistulli, Rudin
    Hoppe, Uta C.
    Lichtenauer, Michael
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 (08)
  • [39] Transcatheter Valve-in-Valve Procedures for Bioprosthetic Valve Dysfunction in Patients With Rheumatic vs. Non-Rheumatic Valvular Heart Disease
    Lopes, Mariana Pezzute
    Egypto Rosa, Vitor Emer
    Palma, Jose Honorio
    Campos Vieira, Marcelo Luiz
    Cordeiro Fernandes, Joao Ricardo
    de Santis, Antonio
    Spina, Guilherme Sobreira
    Fonseca, Rafael de Jesus
    de Sa Marchi, Mauricio F.
    Abizaid, Alexandre
    de Brito, Fabio Sandoli
    Tarasoutchi, Flavio
    Sampaio, Roney Orismar
    Ribeiro, Henrique Barbosa
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [40] Management of patients with subclinical rheumatic heart disease
    Marijon, Eloi
    Celermajer, David S.
    Jouven, Xavier
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 134 (03) : 295 - 296